Filing Flows › Cosmos Health (COSM) › Q1 2026 › vs Q1 2025
Cosmos Health (COSM) Q1 2026 vs Q1 2025 (year over year)
Cosmos Health's revenue rose $4.2M (+31%) from $13.7M in Q1 2025 to $17.9M in Q1 2026. The biggest changes: Wholesale +$4.4M (+35%); Nutraceuticals and Pharmaceuticals −$143K (-15%); Pharma manufacturing −$30K (-11%).
Cosmos Health, Q1 2026: revenue $17.9M (+31% year over year), operating margin -12.2%, net loss $2.8M, operating cash flow −$1.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Wholesale | $16.9M | $12.5M | $4.4M | +35% |
| Nutraceuticals and Pharmaceuticals | $796K | $939K | −$143K | -15% |
| Pharma manufacturing | $238K | $269K | −$30K | -11% |
| Other | $485 | $0 | $485 | — |
| Revenue | $17.9M | $13.7M | $4.2M | +31% |
| Net loss | $2.8M | $818K | $2.0M | +243% |
| Costs & expenses | $20.7M | $14.5M | $6.2M | +43% |
| Operating costs | $20.1M | $14.5M | $5.6M | +38% |
| Interest & other, net | $621K | −$15K | $636K | — |
| Cost of revenue | $16.5M | $11.7M | $4.9M | +42% |
| Sales & marketing | $19K | $28K | −$9K | -31% |
| General & admin | $1.8M | $1.5M | $321K | +22% |
| Other operating costs | $1.7M | $1.4M | $385K | +28% |
| Operating cash sources | $2.8M | $818K | $2.0M | +243% |
| Depreciation & amortization | $347K | $316K | $31K | +10% |
| Share-based compensation | $536K | $557K | −$21K | -4% |
| Working capital & other | $856K | −$241K | $1.1M | — |
| Cash used in operations | $1.1M | $186K | $881K | +473% |
| Net loss absorbed | $2.8M | $818K | $2.0M | +243% |
Questions
How much did Cosmos Health's revenue grow year over year in Q1 2026?
Cosmos Health's revenue rose $4.2M (+31%) from $13.7M in Q1 2025 to $17.9M in Q1 2026.
What drove Cosmos Health's revenue change in Q1 2026?
Wholesale +$4.4M (+35%); Nutraceuticals and Pharmaceuticals −$143K (-15%); Pharma manufacturing −$30K (-11%).